Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.67, n.11, p.1275-1280, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: The aim of this study was to assess the IgE serum levels in juvenile systemic lupus erythematosus patients and to evaluate possible associations with clinical and laboratory features, disease activity and tissue damage. METHODS: The IgE serum concentrations in 69 consecutive juvenile systemic lupus erythematosus patients were determined by nephelometry. IgG, IgM and IgA concentrations were measured by immunoturbidimetry. All patients were negative for intestinal parasites. Statistical analysis methods included the Mann-Whitney, chi-square and Fisher's exact tests, as well as the Spearman rank correlation coefficient. RESULTS: Increased IgE concentrations above 100 IU/mL were observed in 31/69 (45%) juvenile systemic lupus erythematosus patients. The mean IgE concentration was 442.0 +/- 163.4 IU/ml (range 3.5- 9936.0 IU/ml). Fifteen of the 69 patients had atopic disease, nine patients had severe sepsis and 56 patients presented with nephritis. The mean IgE level in 54 juvenile systemic lupus erythematosus patients without atopic manifestations was 271.6 +/- 699.5 IU/ml, and only nine of the 31 (29%) patients with high IgE levels had atopic disease. The IgE levels did not statistically differ with respect to the presence of atopic disease, severe sepsis, nephritis, disease activity, or tissue damage. Interestingly, IgE concentrations were inversely correlated with C4 levels ( r = -0.25, p = 0.03) and with the SLICC/ACR-DI score (r = -0.34, p = 0.005). The IgE concentration was also found to be directly correlated with IgA levels (r = 0.52, p = 0.03). CONCLUSIONS: The present study demonstrated for the first time that juvenile systemic lupus erythematosus patients have increased IgE serum levels. This increase in IgE levels was not related to allergic or parasitic diseases. Our results are in line with the hypothesis that high IgE levels can be considered a marker of immune dysregulation.
Palavras-chave
Juvenile Systemic Lupus Erythematosus, IgE, Intestinal Parasite, Allergic Disease
Referências
  1. Atta AM, 2010, INT ARCH ALLERGY IMM, V152, P401, DOI 10.1159/000288293
  2. Atta AM, 2004, BRAZ J MED BIOL RES, V37, P1497
  3. Barnes PJ, 2005, IMMUNOL ALLERGY CLIN, V25, P251
  4. Becker LC, 1973, HOPKINS MED J, V133, P38
  5. BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606
  6. CAMERON JS, 1994, PEDIATR NEPHROL, V8, P230
  7. Carneiro-Sampaio M, 2008, J CLIN IMMUNOL, V28, pS34, DOI 10.1007/s10875-008-9187-2
  8. DATI F, 1982, CLIN CHEM, V28, P1556
  9. EGIDO J, 1980, ANN RHEUM DIS, V39, P312, DOI 10.1136/ard.39.4.312
  10. ELKAYAM O, 1995, ALLERGY, V50, P94
  11. GEHA RS, 1992, J ALLERGY CLIN IMMUN, V90, P143, DOI 10.1016/0091-6749(92)90064-9
  12. Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506
  13. Gladman DD, 2002, J RHEUMATOL, V29, P288
  14. GOLDMAN JA, 1976, ARTHRITIS RHEUM, V19, P669, DOI 10.1002/1529-0131(197607/08)19:4<669::AID-ART1780190403>3.0.CO;2-E
  15. Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2, DOI 10.1097/01.PCC.0000149131.72248.E6
  16. GRUBER BL, 1988, ARTHRITIS RHEUM, V31, P1000, DOI 10.1002/art.1780310810
  17. Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
  18. LAURENT J, 1986, AM J NEPHROL, V6, P413, DOI 10.1159/000167202
  19. Liphaus BL, 2010, CLINICS, V65, P327, DOI 10.1590/S1807-59322010000300014
  20. Liston A, 2008, NAT REV IMMUNOL, V8, P545, DOI 10.1038/nri2336
  21. Mancini I, 1996, J Pediatr (Rio J), V72, P98
  22. MCPHAUL JJ, 1974, KIDNEY INT, V5, P292, DOI 10.1038/ki.1974.39
  23. MIKECZ K, 1985, ACTA MED HUNG, V42, P59
  24. Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481
  25. Morton S, 1998, ANN RHEUM DIS, V57, P660, DOI 10.1136/ard.57.11.660
  26. PETRI M, 1992, J RHEUMATOL, V19, P265
  27. REBHUN J, 1983, ANN ALLERGY, V50, P34
  28. Ring GH, 1999, SEMIN NEPHROL, V19, P25
  29. ROBERTSON MR, 1976, NEPHRON, V16, P256, DOI 10.1159/000180610
  30. ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.immunol.12.1.227
  31. Rosner B., 2000, FUNDAMENTALS BIOSTAT
  32. SASAI K, 1995, ALLERGY, V50, P370, DOI 10.1111/j.1398-9995.1995.tb01163.x
  33. Sekigawa I, 2002, LUPUS, V11, P426, DOI 10.1191/0961203302lu221oa
  34. Sekigawa I, 2003, CLIN EXP RHEUMATOL, V21, P117
  35. Sekigawa I, 2003, CLIN EXP RHEUMATOL, V21, P683
  36. Sekigawa I, 2004, CLIN EXP RHEUMATOL, V22, P384
  37. SEQUEIRA JF, 1993, LUPUS, V2, P187, DOI 10.1177/096120339300200311
  38. Shahar E, 1997, ISRAEL J MED SCI, V33, P147
  39. Spalding SM, 2000, VER ASS MED BARSIL, V46, P93
  40. TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101
  41. TUMA SN, 1981, AM J NEPHROL, V1, P31, DOI 10.1159/000166485
  42. WITTIG HJ, 1980, J ALLERGY CLIN IMMUN, V66, P305, DOI 10.1016/0091-6749(80)90026-3
  43. Wozniacka A, 2003, MEDIAT INFLAMM, V12, P95, DOI 10.1080/0962935031000097709